Medical Director, Oncology Clinical Development

GlaxoSmithKline; United States; Hybrid; USD 186,000 - 266,000; Full time

Job summary

GlaxoSmithKline in the UK is seeking a Medical Director in Oncology Clinical Development to lead medical monitoring and safety oversight across multiple clinical studies. The role requires an MD with oncology expertise and a strong track record in regulatory interactions.

This is a hybrid position with on-site presence at the Stevenage site and a planned relocation to Cambridge by early 2029. You will work with cross-functional teams to ensure safety and data integrity across the program.

Qualifications

• MD or equivalent medical degree with board certification in oncology/hematology.
• Experience in clinical trial conduct, medical monitoring and safety review.
• Ability to interpret clinical data and provide medical judgment for study design and execution.

Responsibilities

• Provide medical monitoring and safety oversight across assigned clinical studies.
• Lead and oversee safety reviews and regulatory interactions.
• Interpret clinical data to inform decision-making at study and program levels.
• Collaborate cross-functionally withClinical Operations, Biostatistics, Regulatory, and Pharmacovigilance.
• Contribute to protocol development, CDP alignment, and study documents.
• Engage with investigators and KEEs for scientific exchange and external representation.

Skills

Medical monitoring

Safety oversight

Data interpretation

Clinical trial conduct

Cross-functional collaboration

Regulatory interactions

Clinical reasoning

Education

MD or equivalent medical degree

Board certification in oncology/hematology

Tools

GCP/ICH knowledge

Job description

GlaxoSmithKline in the UK is seeking a Medical Director in Oncology Clinical Development to lead medical monitoring and safety oversight across multiple clinical studies. The role requires an MD with oncology expertise and a strong track record in regulatory interactions.

This is a hybrid position with on-site presence at the Stevenage site and a planned relocation to Cambridge by early 2029. You will work with cross-functional teams to ensure safety and data integrity across the program.